pharmaceuticals
pharmaceuticals Articles
With interest rates once again dropping as the geopolitical worries ratchet up, investors are concerned about owning good stocks and receiving dependable dividends. One place that looks very good now...
Published:
Last Updated:
The March 31 short interest data have been compared with the previous figures, and short interest decreased in most of these selected pharmaceutical stocks.
Published:
Last Updated:
Several analysts and market pundits have been positive toward Eli Lilly lately, including now a price target raise at JPMorgan.
Published:
Last Updated:
OncoMed Pharmaceuticals saw its shares crumble after the company announced that Bayer Pharma is terminating its option agreement with the company as well as a missed mid-stage trial.
Published:
Last Updated:
Biohaven Pharmaceutical has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
There is absolutely no denial that a marijuana ETF will generate some investor interest. While this may be a first for true ETF investors, unfortunately many U.S. investors might have a very hard...
Published:
Last Updated:
Shares of Aurinia Pharmaceuticals saw a handy gain on Friday after the company announced plans for the development of a late-stage trial.
Published:
Last Updated:
Shares of Paratek Pharmaceuticals saw a huge gain early on Tuesday after the company provided a critical update on its late-stage pneumonia trial.
Published:
Last Updated:
Cara Therapeutics has priced more than 4 million shares of common stock at $18 per share in a secondary offering valued up to around $92 million.
Published:
Last Updated:
Shares of Akari Therapeutics saw a handy gain on Friday after the firm announced that the FDA granted a Fast Track designation for its treatment of paroxysmal nocturnal hemoglobinuria.
Published:
Last Updated:
Vertex Pharmaceuticals shares were jumping after the firm released results from two Phase 3 studies in the treatment of cystic fibrosis in ages 12 and older.
Published:
Last Updated:
A few biopharma stocks made massive runs on Tuesday morning as the result of clinical trial results and earnings. Although not all of these moves were positive the overall sentiment was positive.
Published:
Last Updated:
The March 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks was mixed.
Published:
Last Updated:
24/7 Wall St. has taken a look at a few companies within the health care sector that might have seen a reaction from the health care vote in Congress, or lack thereof.
Published:
Last Updated:
Esperion Therapeutics and a few other biopharma stocks made massive runs on Monday morning.
Published:
Last Updated: